Comparative features of Asthma with frequent or infrequent exacerbations: A longitudinal study of retrospective and prospective events

References

• Graham LM, Eid N. The impact of asthma exacerbations and preventive strategies. Curr Med Res Opin 2015;31:825–835.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, et al. Frequent exacerbators – a distinct phenotype of severe asthma. Clin Exp Allergy 2014;44:212–221.
   PubMed Web of Science ®Google Scholar
• Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016;9:1–12.
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract 2014;2:741–750.
   PubMed Web of Science ®Google Scholar
• Ritz T, Wittchen HU, Klotsche J, Muhlig S, Riedel O. Asthma trigger reports are associated with low quality of life, exacerbations, and emergency treatments. Ann Am Thorac Soc 2016;13:204–211.
   PubMed Web of Science ®Google Scholar
• Warwick G, Thomas PS, Yates DH. Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology 2013;18:874–884.
   PubMed Web of Science ®Google Scholar
• Green RH, Pavord I. Stability of inflammatory phenotypes in asthma. Thorax 2012;67:665–667.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Dahlen B, Sterk PJ, Nizankowska-Mogilnicka E, Papi A, Bel EH, et al. Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy 2014;69:1198–1204.
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Yegin A, Simons FE, Haselkorn T, Rasouliyan L, Szefler SJ, et al. Evaluation of the national heart, lung, and blood institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Ann Allergy Asthma Immunol 2012;108:81–87.
   PubMed Web of Science ®Google Scholar
• Fajt ML, Wenzel SE. Asthma phenotypes in adults and clinical implications. Expert Rev Respir Med 2009;3:607–625.
   PubMedGoogle Scholar
• Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011;128:1165–1174.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010;181:315–323.
   PubMed Web of Science ®Google Scholar
• Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program. J Allergy Clin Immunol 2007;119:405–413.
   PubMed Web of Science ®Google Scholar
• Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, et al. Canadian thoracic society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19:127–164.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official american thoracic society/european respiratory society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59–99.
   PubMed Web of Science ®Google Scholar
• Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (imi). Thorax 2011;66:910–917.
   PubMed Web of Science ®Google Scholar
• Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma 2010;47:162–165.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
   PubMed Web of Science ®Google Scholar
• Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995;8:899–904.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Hajiro T, Oga T, Tsukino M, Ikeda A. Health-related quality of life in stable asthma: what are remaining quality of life problems in patients with well-controlled asthma? J Asthma 2004;41:57–65.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Canadian asthma consensus group. CMAJ 1999;161:S1–S61.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Bai TR, Becker A, Berube D, Beveridge R, Bowie DM, et al. What is new since the last (1999) canadian asthma consensus guidelines? Can Respir J 2001;8 Suppl A:5A–27A.
   PubMedGoogle Scholar
• Lemiere C, Bai T, Balter M, Bayliff C, Becker A, Boulet LP, et al. Adult asthma consensus guidelines update 2003. Can Respir J 2004;11:9A–18A.
   PubMedGoogle Scholar
• Boulet LP, Boulet V, Milot J. How should we quantify asthma control? Chest 2002;122:2217–2223.
   PubMed Web of Science ®Google Scholar
• LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: validation of the asthma control scoring system. Allergy 2007;62:120–125.
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American thoracic society. Am J Respir Crit Care Med 1995;152:1107–1136.
   PubMedGoogle Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324–1343.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the global lungs 2012 all-age reference equations for spirometry. Eur Respir J 2013;42:1046–1054.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ats clinical practice guideline: interpretation of exhaled nitric oxide levels (feno) for clinical applications. Am J Respir Crit Care Med 2011;184:602–615.
   PubMed Web of Science ®Google Scholar
• Pin I, Gibson PG, Kolendowicz R. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25–29.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996;9:1174–1180.
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, et al. Inflammatory and co-morbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med 2017;195:302–313.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, et al. The effect of treatment with omalizumab, an anti-ige antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005;60:302–308.
   PubMed Web of Science ®Google Scholar
• Tattersfield AE, Harrison TW. Exacerbations of asthma – still room for improvement. Lancet 2001;358:599–601.
   PubMed Web of Science ®Google Scholar
• Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA, Jr. Asthma exacerbations in north American adults: who are the “frequent fliers” in the emergency department? Chest 2005;127:1579–1586.
   PubMed Web of Science ®Google Scholar
• Haselkorn T, Zeiger RS, Chipps BE, Mink DR, Szefler SJ, Simons FE, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2009;124:921–927.
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101:481–489.
   PubMed Web of Science ®Google Scholar
• Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, et al. Predictors of severe exacerbations, poor asthma control, and beta-agonist overuse for patients with asthma. J Allergy Clin Immunol Pract 2014;2:751–758.
   PubMed Web of Science ®Google Scholar
• Yii AC, Tan JH, Lapperre TS, Chan AK, Low SY, Ong TH, et al. Long-term future risk of severe exacerbations: distinct 5-source trajectories of problematic asthma. Allergy 2017;72:1398–1405.
   PubMed Web of Science ®Google Scholar
• Wechsler ME. Getting control of uncontrolled asthma. Am J Med 2014;127:1049–1059.
   PubMed Web of Science ®Google Scholar
• McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006;118:1226–1233.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Busse WW, Wenzel SE, Belozeroff V, Weng HH, Feng J, et al. Use of the asthma control questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011;127:167–172.
   PubMed Web of Science ®Google Scholar
• Schatz M, Zeiger RS, Yang SJ, Chen W, Crawford W, Sajjan S, et al. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest 2012;141:66–72.
   PubMed Web of Science ®Google Scholar
• Blakey JD, Woolnough K, Fellows J, Walker S, Thomas M, Pavord ID. Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm. Prim Care Respir J 2013;22:344–352.
   PubMedGoogle Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• Global initiative for asthma (gina). Global strategy for asthma management and prevention. 2009 2014 [15 December 2016]. Available from: www.ginasthma.org.
   Google Scholar
• O'Byrne PM. Therapeutic strategies to reduce asthma exacerbations. J Allergy Clin Immunol 2011;128:257–263.
   PubMed Web of Science ®Google Scholar
• Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27:483–494.
   PubMed Web of Science ®Google Scholar